A single arm, open label multicentre extension study to evaluate the effectiveness and safety of ocrelizumab in patients with multiple sclerosis previously enrolled in a F. Hoffmann-LA Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trial